A new clinical study suggested a mixture of THC (tetrahydrocannabinol) and CBD (cannabidiol) could offer an effective migraine treatment. Findings presented at the American Headache Society congress described an inhaled formulation containing 6% THC and 11% CBD (source).
- 67.2% of participants experienced a marked reduction in pain intensity within two hours.
- 34.5% became entirely pain-free.
- Effects lasted up to 48 hours in many patients.
- No serious adverse effects were reported.
Researchers leading the work said combined THC and CBD could offer a new option for acute migraine management. These findings were particularly significant for patients not responding to conventional medicines.
Expert opinion, unattributed in the original article:
“These results suggest plant-based cannabinoids could be a strong alternative for migraine treatment. More research is needed, however, to establish long-term safety.”
Why does it matter?
Migraine affects hundreds of millions worldwide, causing lost productivity and major reductions in quality of life. Cannabinoid treatments attract attention particularly for rapid effects and a low side-effect profile.
